XML 110 R94.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Redeemable convertible preferred stock
Redeemable preferred stock
Share capital
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Beginning balance at Dec. 31, 2017 $ 154,800            
Beginning balance (in shares) at Dec. 31, 2017 111,452,020            
Exercise of options     $ 20 $ 798     $ 818
Exercise of options (in shares)     2,090,397        
Share-based compensation       6,919     6,919
Other comprehensive income (loss), net of tax         $ (920)   (920)
Net income (loss)           $ (7,189) (7,189)
Ending balance at Dec. 31, 2018 $ 154,800            
Ending balance (in shares) at Dec. 31, 2018 111,452,020            
Exercise of options     $ 20 1,024     1,044
Exercise of options (in shares)     1,932,934        
Share-based compensation       9,535     9,535
Other comprehensive income (loss), net of tax         862   862
Net income (loss)           (625) (625)
Ending balance at Dec. 31, 2019 $ 154,800            
Ending balance (in shares) at Dec. 31, 2019 111,452,020 3,500          
Ending balance at Dec. 31, 2019     $ 200 30,615 143 (36,321) (5,363)
Ending balance (in shares) at Dec. 31, 2019     19,983,799        
Exercise of options     $ 7 221     228
Exercise of options (in shares)     420,416        
Share-based compensation       2,218     2,218
Acquisition related issuance of common Stock     $ 28 15,515     15,543
Acquisition related issuance of common Stock (in shares)     2,807,902        
Other comprehensive income (loss), net of tax         (58)   (58)
Net income (loss)           (7,479) (7,479)
Ending balance at Mar. 31, 2020 $ 154,800            
Ending balance (in shares) at Mar. 31, 2020 111,452,020            
Ending balance at Mar. 31, 2020     $ 235 48,569 85 (43,800) 5,089
Ending balance (in shares) at Mar. 31, 2020     23,212,117        
Beginning balance at Dec. 31, 2019 $ 154,800            
Beginning balance (in shares) at Dec. 31, 2019 111,452,020 3,500          
Beginning balance at Dec. 31, 2019     $ 200 30,615 143 (36,321) (5,363)
Beginning balance (in shares) at Dec. 31, 2019     19,983,799        
Exercise of options     $ 31 818     $ 849
Exercise of options (in shares)     3,063,712       3,313,666
Share-based compensation       11,074     $ 11,074
Acquisition related issuance of common Stock     $ 28 15,515     15,543
Acquisition related issuance of common Stock (in shares)     2,807,902        
Other comprehensive income (loss), net of tax         4,031   4,031
Net income (loss)           (23,746) (23,746)
Ending balance at Dec. 31, 2020 $ 154,800 $ 10,735          
Ending balance (in shares) at Dec. 31, 2020 111,452,020 3,500          
Ending balance at Dec. 31, 2020     $ 259 79,933 4,174 (60,067) 24,299
Ending balance (in shares) at Dec. 31, 2020     25,855,413        
Ending balance at Dec. 31, 2020 $ 154,800 $ 10,735          
Ending balance (in shares) at Dec. 31, 2020 111,452,020 3,500          
Ending balance at Dec. 31, 2020     $ 259 79,933 4,174 (60,067) 24,299
Ending balance (in shares) at Dec. 31, 2020     25,855,413        
Exercise of options     $ 5 464     469
Exercise of options (in shares)     579,684        
Share-based compensation       4,368     4,368
Other comprehensive income (loss), net of tax         (1,189)   (1,189)
Net income (loss)           (3,508) (3,508)
Ending balance at Mar. 31, 2021 $ 154,800 $ 10,735          
Ending balance (in shares) at Mar. 31, 2021 111,452,020 3,500          
Ending balance at Mar. 31, 2021     $ 264 $ 84,765 $ 2,985 $ (63,575) $ 24,439
Ending balance (in shares) at Mar. 31, 2021     26,435,097